Vanguard Fiduciary Trust
DARE icon

Vanguard Fiduciary Trust’s Dare Bioscience DARE Stock Holding History

Vanguard Fiduciary Trust’s Portfolio DARE Stock Details DARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$193K Buy
91,269
+25,331
+38% +$56.6K ﹤0.01% 3590
2026
Q1 		$120K Buy
+65,938
New +$113K ﹤0.01% 3671

Other funds holding DARE

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $91.6B AUM 29.2% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Vanguard Fiduciary Trust's DARE Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its Dare Bioscience (DARE) stake by 38% in Q2 2026, buying an estimated $56.6K and bringing the position to 91,269 shares worth $193K. The position accounts for ﹤0.01% of the portfolio, ranked #3590.

Vanguard Fiduciary Trust first reported a position in DARE in Q1 2026 and has held it in 2 quarters since. 27 funds tracked by Wall St. Rank hold DARE as of Q2 2026.

  • Vanguard Fiduciary Trust held 91,269 shares of Dare Bioscience worth $193K as of Q2 2026.
  • Vanguard Fiduciary Trust bought 25,331 Dare Bioscience shares in Q2 2026, an estimated $56.6K.
  • Dare Bioscience made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3590 holding.
  • Vanguard Fiduciary Trust first reported a position in Dare Bioscience in Q1 2026 and has held it in 2 quarters since.
  • 27 funds tracked by Wall St. Rank held Dare Bioscience as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.